Research Reports
T-cell Therapy Market Report, Share, Trends, Analysis, Growth and Forecast 2021-2026
Published by Uma Rajagopal
Posted on December 1, 2021
Editorial & Advertiser disclosure
Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
According to IMARC Group latest report titled” T-cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market exhibited strong growth during 2015-2020. The Global T-cell Therapy Market to grow at a CAGR of around 15% during the forecast period (2021-2026). T-cell therapy is a type of immunotherapy that uses altered white blood cells to treat cancer. This procedure involves collecting T-cells from the blood through apheresis, which are later modified in a laboratory to produce special structures known as chimeric antigen receptors (CARs). These re-engineered cells are multiplied and reinfused into the body to eliminate tumor cells. T-cell therapy is primarily used for treating blood cancer and is also being studied for treating various types of cancer.
Request to get the sample report: https://www.imarcgroup.com/t-cell-therapy-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Trends:
The rising prevalence of cancer is creating an inflating demand for targeted anti-cancer therapies with minimal side effects, which is majorly propelling the global T-cell therapy market growth. Apart from this, the onset of coronavirus disease (COVID-19) has prompted researchers to adopt T-cell therapy to treat critically affected patients, which is further supporting the market growth. Moreover, governments of several nations are introducing favorable policies to accelerate oncological research studies, which is creating a positive outlook for the market.
Explore full report with table of contents: https://www.imarcgroup.com/t-cell-therapy-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Amgen Inc.
- Aurora Biopharma Inc.
- bluebird bio Inc
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Gilead Sciences Inc.
- Merck KGaA
- Mustang Bio Inc.
- Novartis AG
- Pfizer Inc.
- Sorrento Therapeutics Inc.
- TCR2 Therapeutics
T-cell Therapy Market Segmentation:
Our report has categorized the market based on region, modality, therapy type and indication.
Market Breakup by Modality:
- Research
- Commercialized
Market Breakup by Therapy Type:
- CAR T-cell based
- T Cell Receptor (TCR) based
- Tumor Infiltrating Lymphocytes (TIL) based
Market Breakup by Indication:
- Hematologic Malignancies
- Lymphoma
- Leukemia
- Myeloma
- Solid Tumors
- Melanoma
- Brain and Central Nervous System
- Liver Cancer
- Others
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
According to IMARC Group latest report titled” T-cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market exhibited strong growth during 2015-2020. The Global T-cell Therapy Market to grow at a CAGR of around 15% during the forecast period (2021-2026). T-cell therapy is a type of immunotherapy that uses altered white blood cells to treat cancer. This procedure involves collecting T-cells from the blood through apheresis, which are later modified in a laboratory to produce special structures known as chimeric antigen receptors (CARs). These re-engineered cells are multiplied and reinfused into the body to eliminate tumor cells. T-cell therapy is primarily used for treating blood cancer and is also being studied for treating various types of cancer.
Request to get the sample report: https://www.imarcgroup.com/t-cell-therapy-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Trends:
The rising prevalence of cancer is creating an inflating demand for targeted anti-cancer therapies with minimal side effects, which is majorly propelling the global T-cell therapy market growth. Apart from this, the onset of coronavirus disease (COVID-19) has prompted researchers to adopt T-cell therapy to treat critically affected patients, which is further supporting the market growth. Moreover, governments of several nations are introducing favorable policies to accelerate oncological research studies, which is creating a positive outlook for the market.
Explore full report with table of contents: https://www.imarcgroup.com/t-cell-therapy-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Amgen Inc.
- Aurora Biopharma Inc.
- bluebird bio Inc
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Gilead Sciences Inc.
- Merck KGaA
- Mustang Bio Inc.
- Novartis AG
- Pfizer Inc.
- Sorrento Therapeutics Inc.
- TCR2 Therapeutics
T-cell Therapy Market Segmentation:
Our report has categorized the market based on region, modality, therapy type and indication.
Market Breakup by Modality:
- Research
- Commercialized
Market Breakup by Therapy Type:
- CAR T-cell based
- T Cell Receptor (TCR) based
- Tumor Infiltrating Lymphocytes (TIL) based
Market Breakup by Indication:
- Hematologic Malignancies
- Lymphoma
- Leukemia
- Myeloma
- Solid Tumors
- Melanoma
- Brain and Central Nervous System
- Liver Cancer
- Others
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800